Unknown

Dataset Information

In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.


ABSTRACT:

SUBMITTER: Lund T 

PROVIDER: S-EPMC11018794 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature